Harvesting Health and Reaping Profits: The $2.2 Million Cure for Sickle-Cell Disease 

[I]n the period between late 2023 and early 2024, a groundbreaking development has emerged: the Federal Drug Authority (FDA) and the European Union (EU) approvals of a gene-editing therapy that has the potential to change the course of treatment of [Sickle Cell Disease] forever.

Explaining South Africa v Israel at the ICJ

While many states have spoken out in support of Palestine, South Africa was the only party to take the initiative of bringing a case before the ICJ. While the most obvious motivating factor behind this is no doubt Israel’s conduct in the region, there are further reasons to explain this, including a shared history of solidarity between civil rights movements in South Africa and Palestine.